🇺🇸 US

BMY revenue, net income and debt history (Bristol-Myers Squibb Company)

Quick answer

Bristol-Myers Squibb Company (BMY) reported revenue of $48.19B and net income of $7.05B for the fiscal year ended 2025-12-31, down 0.2% from $48.30B the year before, per its 10-K filed with the SEC on 2026-02-11. Long-term debt stood at $44.83B.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Fiscal yearRevenueNet incomeLong-term debt
2025 (FY ending 2025-12-31)$48.19B$7.05B$44.83B
2024 (FY ending 2024-12-31)$48.30B-$8.95B$49.43B
2023 (FY ending 2023-12-31)$45.01B$8.03B$39.53B
2022 (FY ending 2022-12-31)$46.16B$6.33B$38.95B
2021 (FY ending 2021-12-31)$46.38B$6.99B$44.37B
2020 (FY ending 2020-12-31)$42.52B-$9.02B$50.34B
2019 (FY ending 2019-12-31)$26.14B$3.44B$46.15B
2018 (FY ending 2018-12-31)$22.56B$4.92B$6.89B
2017 (FY ending 2017-12-31)$20.78B$1.01B$6.97B
2016 (FY ending 2016-12-31)$19.43B$4.46B$5.72B

Related

Last updated 2026-10-16. Data only, not financial or tax advice.